Financial HealthVenture’s net cash position, with zero borrowings, improved to SGD1.19bn, which should support a repeat of the attractive dividend yield.
Growth ProspectsThe group has a healthy pipeline of new product introduction at different stages across its various tech domains, which should help to drive growth in 2H24 and beyond.
Strategic PositioningWith the majority of its manufacturing facilities in Malaysia, the group is well-positioned to support customers seeking to diversify their operations outside of China to mitigate geopolitical risks.